Review of Glucagon‐Like Peptide‐1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus in Patients With Chronic Kidney Disease and Their Renal Effects
Journal of Diabetes - United States
doi 10.1111/1753-0407.12969
Full Text
Open PDFAbstract
Available in full text
Date
August 14, 2019
Authors
Publisher
Wiley